Ramazzini Hospital, Modena, Italy
Insulin glargine safe and effective in improving glycemic control in diabetes
Published in Physician Law Weekly, September 27th, 2006
According to recent research from Italy, "We wanted to assess the effectiveness and safety of glargine in the treatment of patients with type 2 diabetes mellitus in secondary failure and/or with severe comorbidities ('T2DM group'), and patients with secondary diabetes after corticosteroid and/or anticancer treatment ('secondary DM group'). We reviewed the records of patients on glargine from August 1, 2004 to July 30, 2005. The after-minus-before change in HbA1c was the main outcome measure."
A.V. Ciardullo and colleagues working with the Ramazzini...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2006-09-27)
More Articles from Physician Law Weekly
- AGA Medical
AGA Medical files suit in Germany alleging patent infringement - Align Technology
Federal Circuit Court of Appeals reverses District Court, finds six Align patent claims invalid - Business Update
Florida insurance office approves registration of Phyhealth's medical malpractice insurance - Cardiff University, U.K.
Nasal septal surgery patient selection is improved with a subjective ordinal scale - Cook Biotech
Cook Biotech resolves to pursue life sciences patent infringement case against ACell Inc. - CytoCore
CytoCore, Inc. announces quarterly progress - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
